Category Archives: Press Release

GBF today announced a continued strategic partnership with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells.

GBF today announced a continued strategic partnership with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells.

GBF today announced a continued strategic partnership with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells.

GBF will serve academic, clinical and commercial investigators, both Colorado-based and nationwide, looking to translate their discoveries into clinical-grade products suitable for investigational use in humans.

Heather Pidcoke, a lymphoma patient, is among the first to receive CAR-T cells created at the Gates Biomanufacturing Facility just steps from CU Anschutz.  Now she is in complete remission.

GBF has passed an important landmark in manufacturing its first clinical trial-grade product for direct infusion into patients.

Lilian Hoffecker and I visited the Gates Biomanufacturing Facility (GBF) located in Biosciences Park Center on Montview that opened in April.

My old friend Charlie Gates was a visionary. So it was ironic that he suffered from macular degeneration, an eye condition that can lead to blindness.

Some of our young faculty who literally have developed new techniques for cell expansion — that no one else in the world has been able to do — would be lost to other institutions, because they’re driven to get (those technologies) into the clinic.

The new Gates Biomanufacturing Facility (GBF) will serve academic, clinical and commercial investigators, both Colorado-based and nationwide, looking to translate their discoveries into clinical-grade products suitable for investigational use in humans.